BRIEF-Bayer says sees closing of Merck & co OTC deal in second-half 2014

FRANKFURT Tue May 6, 2014 6:08am EDT

Related Topics

FRANKFURT May 6 (Reuters) - Bayer AG : * Says buy Merck & co inc's otc drugs business for$14.2 billion * Says acquisition will give it the global number two position in

non-prescription products * Says plans to finance acquisition with bridge facility provided by Bank of

America, Merrill Lynch, bnp paribas and mizuho, * Says sees closing in the second half of 2014. * Says entered into co-development and co-commercialization deal with Merck in

soluble guanylate cyclase (sgc) modulators

FILED UNDER: